EMA Provides Rapid Feedback on GSK Ebola Vaccine
European Medicines Agency has given 'rapid scientific advice'
For the first time in the current Ebola outbreak, the European Medicines Agency (EMA) has given ‘rapid scientific advice’ using an accelerated procedure to GSK on its development plan for an Ebola vaccine.
Through rapid scientific advice, developers can receive EMA’s expert opinion and advice on topics such as clinical trial design, manufacturing-related questions as well as safety monitoring of medicines. EMA established this procedure to contribute to the global response against Ebola and to help companies speed up the development of vaccines and treatments.
EMA hopes this procedure will help companies to generate the robust data and information needed to assess that treatments and vaccines against Ebola actually work, are acceptably safe and of high quality. It says it will assess any data in a ‘rolling review’, as soon as they become available.
The initial review and any subsequent updates will be shared with healthcare decision-makers in countries affected by the current Ebola outbreak. This will help them to take informed decisions on whether and how they want to use vaccines and medicines in their specific situation.
Read the full release here.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
